Benzamides (chemistry) < Benzamides (diagnostic use) < Benzamides (metabolism)

Facettes :

List of bibliographic references indexed by Benzamides (diagnostic use)

Number of relevant bibliographic references: 14.

Ident.	Authors (with country if any)	Title
001280 (2011)	Kotaro Ogaki [Japon] ; Yumiko Motoi [Japon] ; Yuanzhe Li [Japon] ; Hiroyuki Tomiyama [Japon] ; Natsue Shimizu [Japon] ; Masashi Takanashi [Japon] ; Atsushi Nakanishi [Japon] ; Kazumasa Yokoyama [Japon] ; Nobutaka Hattori [Japon]	Visual grasping in frontotemporal dementia and parkinsonism linked to chromosome 17 (microtubule‐associated with protein tau): A comparison of N‐Isopropyl‐p‐[123I]‐iodoamphetamine brain perfusion single photon emission computed tomography analysis with progressive supranuclear palsy
003477 (2006)	Stefanie Klaffke [Allemagne] ; Andrea A. Kuhn [Allemagne] ; Michail Plotkin [Allemagne] ; Holger Amthauer [Allemagne] ; Daniel Harnack [Allemagne] ; Roland Felix [Allemagne] ; Andreas Kupsch [Allemagne]	Dopamine transporters, D2 receptors, and glucose metabolism in corticobasal degeneration
003C63 (2004)	Andrew H. Evans [Royaume-Uni] ; Durval C. Costa ; Sveto Gacinovic [Royaume-Uni] ; Regina Katzenschlager [Royaume-Uni] ; John D. O'Sullivan [Australie] ; Simon Heales [Royaume-Uni] ; Phillip Lee [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni]	L‐dopa–responsive Parkinson's syndrome in association with phenylketonuria: In vivo dopamine transporter and D2 receptor findings
003D83 (2004)	W. Farid Abdo [Pays-Bas] ; Daniëlle De Jong [Pays-Bas] ; Jan C. M. Hendriks [Pays-Bas] ; Martin W. I. M. Horstink [Pays-Bas] ; Berry P. H. Kremer [Pays-Bas] ; Bastiaan R. Bloem [Pays-Bas] ; Marcel M. Verbeek [Pays-Bas]	Cerebrospinal fluid analysis differentiates multiple system atrophy from Parkinson's disease
003E30 (2004)	Sylvia M. Boesch [Autriche] ; Eveline Donnemiller [Autriche] ; Jörg Müller [Autriche] ; Klaus Seppi [Autriche] ; Helga Weirich-Schwaiger [Autriche] ; Werner Poewe [Autriche] ; Gregor K. Wenning [Autriche]	Abnormalities of dopaminergic neurotransmission in SCA2: A combined 123I‐βCIT and 123I‐IBZM SPECT study
003F37 (2003)	Klaus L. Leenders [Pays-Bas]	Significance of non‐presynaptic SPECT tracer methods in Parkinson's disease
004117 (2003)	Carsten Buhmann [Allemagne] ; Alexandra Bussopulos [Allemagne] ; Matthias Oechsner [Allemagne]	Dopaminergic response in Parkinsonian phenotype of Machado‐Joseph disease
004284 (2002)	Guy Arnold [Allemagne] ; Klaus Tatsch [Allemagne] ; Eduardo Kraft [Allemagne] ; Wolfgang H. Oertel [Allemagne] ; Johannes Schwarz [Allemagne]	Steele‐Richardson‐Olszewski‐Syndrome: Reduction of dopamine D2 receptor binding relates to the severity of midbrain atrophy in vivo: 123IBZM SPECT and MRI study
004F86 (1998)	Naumann [Allemagne] ; Walter Pirker [Autriche] ; K. Reiners [Allemagne] ; Klaus W. Lange [Allemagne] ; Georg Becker [Allemagne] ; Thomas Brücke [Allemagne]	Imaging the pre‐ and postsynaptic side of striatal dopaminergic synapses in idiopathic cervical dystonia: A SPECT STUDY Using [123I] epidepride and [123I] β‐CIT
005098 (1998)	Wenning [Autriche] ; Eveline Donnemiller [Autriche] ; Roberta Granata [Autriche] ; Georg Riccabona [Autriche] ; Werner Poewe [Autriche]	123I‐β‐CIT and 123I‐IBZM‐SPECT scanning in levodopa‐naive Parkinson's disease
005099 (1998)	Schwarz [Allemagne] ; Klaus Tatsch [Allemagne] ; Thomas Gasser [Allemagne] ; Guy Arnold [Allemagne] ; Oliver Pogarell [Allemagne] ; Gais Künig [Allemagne] ; Wolfgang H. Oertel [Allemagne]	123I‐IBZM binding compared with long‐term clinical follow up in patients with de novo parkinsonism
005633 (1996)	Jauss [Allemagne] ; P. Krack [Allemagne] ; M. Franz [Allemagne] ; R. Klett [Allemagne] ; R. Bauer [Allemagne] ; B. Gallhofer [Allemagne] ; W. Dorndorf [Allemagne]	Imaging of dopamine receptors with [123I]iodobenzamide single‐photon emission–computed tomography in neuroleptic malignant syndrome
005E03 (1993)	L. Schelosky [Allemagne] ; J. Hierholzer [Allemagne] ; J. Wissel [Allemagne] ; M. Cordes [Allemagne] ; Poewe [Allemagne]	Correlation of clinical response in apomorphine test with D2‐receptor status as demonstrated by 123I IBZM‐SPECT
005F93 (1992)	Schwarz [Allemagne] ; K. Tatsch [Allemagne] ; T. Vogl [Allemagne] ; C. M. Kirsch [Allemagne] ; C. Trenkwalder [Allemagne] ; G. Arnold [Allemagne] ; T. Gasser [Allemagne] ; W. H. Oertel [Allemagne]	Marked reduction of striatal dopamine D2 receptors as detected by 123IBZM‐SPECT in a Wilson's disease patient with generalized dystonia

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Benzamides (diagnostic use)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Benzamides (diagnostic use)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Benzamides (diagnostic use)
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024